Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available-Reference-Cited by-同舟云学术

Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available

Published:2021-09 Issue: Volume:338 Page:168-173
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Kawashima Hideyuki,Serruys Patrick W.,Mylotte Darren,Rosseel Liesbeth,Amat-Santos Ignacio J.,Rao Ravinder Singh,Onuma Yoshinobu,Wijns William,Abdel-Wahab Mohamed,Baumbach Andreas,Soliman Osama

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery;van Gils;EuroIntervention,2016

2. Prosthesis oversizing in balloon-expandable transcatheter aortic valve implantation is associated with contained rupture of the aortic root;Blanke;Circ. Cardiovasc. Interv.,2012

3. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): an expert consensus document of the Society of Cardiovascular Computed Tomography;Blanke;J. Cardiovasc. Comput. Tomogr.,2019

4. Computed tomography-based oversizing degrees and incidence of paravalvular regurgitation of a new generation Transcatheter heart valve;Blanke;JACC Cardiovasc. Interv.,2017

5. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial;Binder;J. Am. Coll. Cardiol.,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial;The Lancet;2024-06

2. Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis — A real-world Indian experience (The OCTACOR India Study);Cardiovascular Revascularization Medicine;2024-06

3. German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation—Outcomes of the MYLAND (MYvaL germAN stuDy) Study;Journal of Clinical Medicine;2024-05-28

4. LANDMARK Trial: Randomised Non-Inferiority Comparison of Early Outcomes of Newer Generation Myval THV Series with Contemporary Valves (Sapien and Evolut THV Series) in Real-World Patients with Symptomatic Native Aortic Stenosis;2024

5. Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication;International Journal of Cardiology;2023-07